Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2005
03/16/2005EP1513502A1 Combination therapy for respiratory disorders
03/16/2005EP1513500A2 Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
03/16/2005EP1513499A1 Ibuprofen suspension
03/16/2005EP1513498A1 Method for modulation of drug release from multiphase implantable or insertable medical devices and a process for manufacturing such devices
03/16/2005EP1513497A2 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
03/16/2005EP1513496A1 Immediate release pharmaceutical formulation
03/16/2005EP1513495A1 Modified release pharmaceutical formulation
03/16/2005EP1513494A2 Film-shaped mucoadhesive administration form for administering cannabis active ingredients
03/16/2005EP1513493A2 Analgesics
03/16/2005EP1513482A2 Topical use of at least one double-stranded rna oligonucleotide (ds rna)
03/16/2005EP1513419A2 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress
03/16/2005EP1513418A2 Use of pullulan as a slowly digested carbohydrate
03/16/2005EP1513403A1 Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders
03/16/2005EP1513402A1 Improved inhibitors of adp-ribosyl transferases, cyclases, and hydrolases
03/16/2005EP1474085A4 In situ bonds
03/16/2005EP1453510A4 Neurotransmitter balance chemotherapy
03/16/2005EP1435899A4 A composition for promoting hair growth
03/16/2005EP1425283B1 Novel 4-aminofuropyrimidines and the use thereof
03/16/2005EP1399436B1 Oxytocin agonists
03/16/2005EP1392699B1 6h-oxazolo 4,5-e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
03/16/2005EP1355903B1 Pyrazole derivatives against tgf overexpression
03/16/2005EP1355894B1 Amidinophenylalanine derivatives as thrombin inhibitors
03/16/2005EP1353929B1 Streptogramin derivatives preparation thereof and compositions containing same
03/16/2005EP1353693B1 Pharmaceutical combination containing a 4-quinazolineamine and paclitaxel, carboplatin or vinorelbine for the treatment of cancer
03/16/2005EP1351962B1 Thienopyrimidine
03/16/2005EP1351647A4 Compositions and methods for treating hyperpigmentation
03/16/2005EP1345612B1 Use of low molecular heparin for treating osteoarthritis
03/16/2005EP1311476B1 Aza-amino acid derivatives (factor x a?-inhibitors 15)
03/16/2005EP1268784B1 Genes involved in intestinal inflammatory diseases and use thereof
03/16/2005EP1242095A4 Antimicrobial compositions and methods of use
03/16/2005EP1233959B1 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/16/2005EP1226119B1 Tyrosine kinase inhibitors
03/16/2005EP1203585B1 Anti-ischemic agent
03/16/2005EP1189640B1 Complex of eletriptan and sulphobutylether-cyclodextrin and its use for the treatment of migraine
03/16/2005EP1178774B1 Antiperspirant and deodorant compositions containing cyclohexasiloxane
03/16/2005EP1165134B1 Use of anti-ferritin monoclonal antibodies in the treatment of some cancers
03/16/2005EP1163200B9 Method of industrial-scale purification of lactic acid
03/16/2005EP1146873B1 Anti-androgens and methods for treating disease
03/16/2005EP1140900B1 Pyrazole compounds and uses thereof
03/16/2005EP1140054B1 Bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions
03/16/2005EP1135134B1 Use of neurotrophic factor stimulators for the treatment of ophthalmic neurodegenerative diseases
03/16/2005EP1135125B1 Controlled-release dosage forms comprising zolpidem or a salt thereof
03/16/2005EP1117296B1 Combination of bisphosphonate and tetracycline
03/16/2005EP1115371B1 Oral care compositions
03/16/2005EP1097922B1 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient
03/16/2005EP1096975B1 Use of a3 adenosine receptor antagonists in the manufacture of a medicament for reducing intraocular pressure
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP1032401B1 Method for inhibiting cytokine production by cells
03/16/2005EP1005589B1 Resin-impregnated belt having a texturized outer surface for application on papermaking machines
03/16/2005EP1000065B1 Preparation of oxymorphone, oxycodone and derivatives
03/16/2005EP0965327B1 Wrinkling modifiers
03/16/2005EP0952772B1 Methods of use of mononuclear phagocytes to promote axonal regeneration
03/16/2005EP0942746B1 Inhibition of invasive remodelling
03/16/2005EP0929553B1 Pyrimidine derivatives and processes for the preparation thereof
03/16/2005EP0907737B1 Il-6 mutein
03/16/2005EP0874625B1 Indane derivatives for antipsychotic compositions
03/16/2005EP0870503B1 use of vitamin D derivatives for the manufacture of a medicament for treating MALIGNANT TUMOR METASTASIS
03/16/2005EP0869966B1 Prodrugs of thrombin inhibitors
03/16/2005EP0861329B1 Dodecahedral adenoviral protein complex, composition containing same and uses thereof
03/16/2005EP0854724B1 Method of treating the navicular disease in horses
03/16/2005EP0837681B1 Use of 19-nor-vitamin d compounds for the prevention of hyperphosphatemia in kidney disorder patients
03/16/2005EP0808164B1 Use of prolactin modulators and diet for the manufacture of a medicament for the treatment of obesity
03/16/2005EP0774964B1 Controlled local delivery of chemotherapeutic agents for treating solid tumors
03/16/2005EP0769917B2 Nervonic acid compositions
03/16/2005EP0746321B1 Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
03/16/2005CN1596314A Method of determining a chemotherapeutic regimen based on ercc1 and ts expression
03/16/2005CN1596269A A novel G protein-coupled receptor, gave 10
03/16/2005CN1596266A Specific binding agents of human angiopoietin-2
03/16/2005CN1596263A Aryl fused azapolycyclic compounds
03/16/2005CN1596259A Crystals of taxane derivative and process for their production
03/16/2005CN1596258A Adenosine A2a receptor antagonists
03/16/2005CN1596257A Novel crystalline compound
03/16/2005CN1596255A Chemokine receptor binding heterocyclic compounds with enhanced efficacy
03/16/2005CN1596254A Process for the prereparation of compositions having an increased amount of pharmaceutically active salts of rotamers
03/16/2005CN1596253A Spiro-hydantoin compounds useful as anti-inflammatory agents
03/16/2005CN1596251A Piperazine derivatives having SST1 antagonistic activity
03/16/2005CN1596250A Paclitaxel solvates
03/16/2005CN1596249A Benzoxazine and benzothiazine derivatives and parmaceutical compositions containing them
03/16/2005CN1596248A Phenoxy amine compounds and compositions for delivering active agents
03/16/2005CN1596247A Lactam derivatives as antagonists for human 11CBY receptors
03/16/2005CN1596246A Preventives or remedies for alzheimer's disease or amyloid protein fibrosis inhibitors containing nitrogen-containing heteroaryl compounds
03/16/2005CN1596240A Chalcone derivatives and their use to treat diseases
03/16/2005CN1596141A Conjugated anti-psychotic drugs and uses thereof
03/16/2005CN1596128A Pharmaceutical compositions of 5, 7, 14-triazatetracyclo[10.3.1.0(2, 11).0(4, 9)]-hexadeca-2(11)3, 5, 7, 9-pentaene
03/16/2005CN1596127A Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound
03/16/2005CN1596121A Prevention and treatment of restenosis by local administration of drug
03/16/2005CN1596119A Modification of feeding behavior
03/16/2005CN1596118A Therapeutical treatments
03/16/2005CN1596116A Anticancer compositions
03/16/2005CN1596115A Treatment of hyperproliferative diseases using active vitamin D analogues
03/16/2005CN1596114A Substituted 1, 4-benzodiazepines and uses thereof for the treatment of cancer
03/16/2005CN1596113A Method of treating depression with delta receptor agonist compounds
03/16/2005CN1596112A Benzothiazole derivatives
03/16/2005CN1596111A Methods and compositions for ameliorating the undesirable effects of chemotherapy
03/16/2005CN1596110A Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
03/16/2005CN1596109A Formulation of amino acids and riboflavin useful to reduce toxic effects of cytotoxic chemotherapy
03/16/2005CN1596108A Aqueous ECABET sodium solution preparation
03/16/2005CN1596107A Prevention of miscarriage with immunomodulating non-endogenous gestagen compounds
03/16/2005CN1596106A Use of trifluoroacetyl alkyl-substituted phenyl derivatives, phenol derivatives, and benzoyl derivatives in the treatment and/or prophylaxis of obesity and accompanying diseases and/or secondary disea
03/16/2005CN1596105A Transdermal therapeutic systems containing steroid hormones and propylene glycol monocaprylate
1 ... 4754 4755 4756 4757 4758 4759 4760 4761 4762 4763 4764 4765 4766 4767 4768 4769 4770 4771 4772 4773 4774 ... 7860